Munro D D, Robinson T W, du Vivier A W, France D M, Clayton R, Sparkes C G
Arch Dermatol. 1977 May;113(5):599-601.
Betamethasone 0.1% as valerate in an ointment base and fluocinonide 0.05% in a fatty alcohol propylene glycol (FAPG) base have been compared in a double-blind trial of 76 patients with either eczema or psoriasis. The results show betamethasone valerate ointment to be significantly (P less than.05) superior to fluocinonide FAPG in the treatment of both these skin conditions. In the light of publications from other studies on betamethasone valerate cream this trial indicates that the ointment base considerably increases the efficacy of betamethasone valerate.
在一项针对76例湿疹或银屑病患者的双盲试验中，对0.1%戊酸倍他米松软膏基质和0.05%氟轻松脂醇丙二醇（FAPG）基质进行了比较。结果显示，戊酸倍他米松软膏在治疗这两种皮肤病方面明显（P<0.05）优于氟轻松FAPG。根据其他关于戊酸倍他米松乳膏的研究出版物，该试验表明软膏基质显著提高了戊酸倍他米松的疗效。
